Difference between revisions of "Bupropion-fluvoxamine"
From Psychiatrienet
| Line 10: | Line 10: | ||
* No wash-out period is needed. | * No wash-out period is needed. | ||
* Bupropion and its metabolites have long elimination times, so plasma concentrations will reduce gradually. | * Bupropion and its metabolites have long elimination times, so plasma concentrations will reduce gradually. | ||
| + | {{lowlevels}} | ||
}} | }} | ||
Revision as of 15:29, 7 October 2015
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
Switch medication from bupropion to fluvoxamine.[1] [2]
Stop bupropion - Before day 1: Gradually reduce dosage of bupropion to a maximum of 150 mg/ day.
- Day 1: Stop administration of bupropion
Start fluvoxamine- Day 2: Start fluvoxamine in normal dosage of 50 mg/day.
- After 3 weeks: If necessary increase dosage gradually to 100-300 mg/day
More information- No wash-out period is needed.
- Bupropion and its metabolites have long elimination times, so plasma concentrations will reduce gradually.
- Pharmacokinetic interaction is not important because of low plasma levels.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
